The Accounts UK companies data
Follow The Accounts on X

ASTELLAS PHARMA EUROPE LTD.

#02486792 · Active · Incorporated 1990-03-29 (36y 7m) · Last filing 2026-10-14 (this month)
Consumer Discretionary · SIC 46460 · G Wholesale & Retail Trade; Repair of Motor Vehicles · Full accounts
Accounts due 2027-12-31 (in 1y) · Confirmation due 2027-02-01 (in 3 months) · No watchouts on the register

Get an alert when ASTELLAS PHARMA EUROPE LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

—

Latest balance sheet

Net assets

£360k

EUR 414,052

+3.4% vs 2025

Employees

582

+16.2% vs 2025

Profit before tax

£256k

EUR 294,600

-1.5% lowest in 3 filed years

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31

Metric Trend 2024-03-312025-03-312026-03-31 Δ vs prior
Turnover £1,675,986,488£2,073,615£2,299,478 +10.9%
Operating profit £14,978,192£124,153£191,440 +54.2%
Profit before tax £123,307,107£259,951£255,951 -1.5%
Net profit £112,554,520£234,838£228,934 -2.5%
Cash ——— —
Total assets less current liabilities £596,500,470£357,789£379,081 +6%
Net assets £596,500,470£348,023£359,732 +3.4%
Equity £596,500,470£348,023£359,732 +3.4%
Average employees —501582 +16.2%
Wages £68,707,774£85,525£87,965 +2.9%
Directors' remuneration £2,112,375£2,097£2,293 +9.3%
Directors' pension contributions £284,786£144£81 -43.8%
Highest paid director £552,467£506£622 +22.9%

Figures converted to GBP from EUR at 0.869 per EUR (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-312026-03-31
Operating margin 0.9%6.0%8.3%
Net margin 6.7%11.3%10.0%
Return on capital employed 2.5%34.7%50.5%
Gearing (liabilities / total assets) 64.8%91.2%91.6%
Current ratio 1.37x1.16x1.15x
Interest cover 72.98x——

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 2 times since incorporation

  1. ASTELLAS PHARMA EUROPE LTD. 2005-05-03 → present
  2. YAMANOUCHI U.K. LIMITED 1990-05-29 → 2005-05-03
  3. LUPINBROOK LIMITED 1990-03-29 → 1990-05-29

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
Ernst & Young
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Based on analysis performed, consideration of appropriate forecasts and information made available to us, the directors have no reason to believe that there is a risk around going concern of the Company for a period of twelve months from the approval of the financial statements.”

Group structure

  1. ASTELLAS PHARMA EUROPE LTD. · parent
    1. Astellas Pharma S.A.S. 100% · France
    2. Astellas Pharma Ges.m.b.H. 100% · Austria
    3. Astellas Pharma s.r.o. 80% · Czechia
    4. Astellas Pharma GmbH 100% · Germany
    5. Astellas Pharma Co. Ltd. 100% · Ireland
    6. Astellas Pharmaceuticals AEBE 99.99% · Greece
    7. Astellas Pharma Kft. 100% · Hungary
    8. Astellas Pharma S.A. 75% · Spain
    9. Astellas Pharma S.p.A. 94.96% · Italy
    10. Astellas Pharma A/S 100% · Denmark
    11. Astellas Farma Limitada 99.99% · Portugal
    12. Astellas Pharma AB 100% · Sweden
    13. Astellas Pharma Sp.z.o.o. 100% · Poland
    14. Astellas Pharma EOOD 100% · Bulgaria
    15. Astellas Pharma Ltd. 100% · United Kingdom
    16. Astellas d.o.o., Croatia 100% · Croatia
    17. Astellas Pharma S.r.l. 99.93% · Romania
    18. Astellas Pharma Slovenia 100% · Slovenia
    19. Astellas Engineered Small Molecules U.K. Limited 100% · United Kingdom
    20. Astellas Pharma Capability Centre Poland Sp. z o.o. 100% · Poland

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

5 active · 66 resigned

Name Role Appointed Born Nationality
DEMPSEY, Martina Mary, Ms. Director 2023-04-01 Dec 1965 Irish
FLOWERDEW, Lesley Ann Director 2022-04-01 Oct 1967 British
HUGHES - BEDNAR, Veronika, Dr Director 2026-06-19 Jan 1984 British
MORTLOCK, Andrew Austen, Dr. Director 2025-05-24 Dec 1965 British
SCHADDELEE, Marloes Petra Director 2022-07-01 Nov 1972 Dutch
Show 66 resigned officers
Name Role Appointed Resigned
ABE, Yasuhide Secretary — 1994-10-01
HATANAKA, Kazuyoshi Secretary 2003-06-27 2007-01-11
HINCHLIFFE, Sally Anne Secretary 2014-04-25 2025-06-20
IMANISHI, Masayuki Secretary 2007-01-11 2008-04-07
KATOGI, Yoshio Secretary 1998-08-01 1999-04-01
NAKAJIMA, Hajime Secretary 1999-10-01 2002-04-01
TANAKA, Akihiro, Dr Secretary 2002-04-01 2003-08-01
TSCHUDIN, Jean-Charles Secretary 2003-06-27 2003-06-28
UCHIYAMA, Hirokatsu Secretary 1994-10-01 1998-09-04
YAMAMOTO, Hirokazu, Dr Secretary 1998-11-06 1999-10-01
ABE, Yasuhide Director — 1994-10-01
BOHNER, Jochen Norbert Director 2018-07-06 2020-12-17
CHIHARA, Osamu Director 2012-04-20 2012-06-19
CUNHA DE PAULA, Thais, Ms. Director 2020-12-17 2022-03-31
GANE, Richard Hugh Director 2021-11-15 2026-06-19
HARA, Hiromu, Dr Director 1997-08-01 1998-09-04
HARFORD, Joseph Francis Director — 1998-01-15
HATANAKA, Kazuyoshi Director 2003-06-27 2005-07-22
HATANAKA, Yoshihiko Director 2005-05-26 2006-04-01
HIRANO, Masaaki Director 2018-04-01 2020-12-17
IIZUKA, Hisakazu Director — 1993-06-29
ISHII, Yasuo Director 2001-01-01 2008-03-31
JANSEN VAN RENSBURG, Eugene Theodorus Director 2015-07-20 2018-07-06
JONES, Kenneth Wade Director 2011-04-01 2016-02-25
KATOGI, Yoshio Director 1998-08-01 1999-04-01
KAWAISHI, Kiyoshi Director 2001-01-01 2002-07-01
KIMURA, Kaoru Director 1998-08-01 2000-08-02
KOBAYASHI, Yohshi Director 1996-08-01 1998-09-04
KOSCHE, Dirk Armin, Dr Director 2018-07-06 2021-12-31
LAMBERT, Keith Philip Director 2021-04-01 2023-05-31
MASUDA, Yasumasa Director 2009-04-01 2012-04-19
MATSUI, Hidefumi Director 1995-11-01 1997-08-01
MATSUI, Yukio Director 2016-04-01 2018-07-06
MATSUI, Yukio Director 2007-11-01 2012-04-17
MATSUMOTO, Junichiro Director 1993-06-29 1996-08-01
MCDOUGALL, Alan, Dr Director 2023-09-01 2025-03-31
MIYAKE, Masatoshi Director 2006-04-01 2008-05-01
MORIOKA, Shigao Director — 1996-08-01
NAKAJIMA, Hajime Director 1999-10-01 2002-04-01
NOGAWA, Hiroshi Director 2012-04-01 2013-09-30
NOGAWA, Hiroshi Director 2007-10-11 2009-04-01
NOGAWA, Hiroshi Director 2004-06-01 2005-07-22
OKAMURA, Naoki Director 2016-04-01 2018-04-01
ONODA, Masayoshi Director — 1996-08-01
PEARSON, Adam John Director 2020-04-01 2022-06-30
SAITOH, Ken-Ichiro Director — 1996-05-13
SAKAE, Yasuo Director 2013-10-01 2016-04-01
SCHULZE, Daniel Benjamin Matthias Director 2016-04-04 2021-11-14
SHIMAMOTO, Kentaro Director 2023-06-02 2023-08-31
STANDER, Nicolaas Jacobus Director 2015-03-10 2015-07-20
TAKAHASHI, Shigekazu Director 2000-04-01 2001-01-01
TAKAYAMA, Mitsuyoshi Director 2005-05-26 2007-10-11
TAKEDA, Chikashi Director 2012-06-20 2017-03-31
TAMURA, Toshinari, Dr Director 2002-07-01 2003-06-27
TANAKA, Akihiro, Dr Director 2002-04-01 2003-08-01
TEMKO, Jerrold Howard Director 2015-03-10 2016-02-22
TSCHUDIN, Jean-Charles Director 2003-06-27 2004-04-30
UCHIYAMA, Hirokatsu Director 1994-10-01 1998-09-04
UEDA, Hidehiko Director 2000-08-01 2001-01-01
YAMAMOTO, Hirokazu, Dr Director 1998-08-01 2000-04-01
YAMAZAKI, Atsuki Director 2005-05-26 2006-04-01
YOKOTA, Chihiro Director 2005-05-26 2009-10-29
YOSHIDA, Masao Director 2008-04-01 2011-04-01
YOSHIDA, Masao Director 2006-04-01 2007-10-31
YOSHIMITSU, Toru Director 2017-04-01 2020-03-31
ZIELER, Claus Gerhard Director 2022-01-01 2023-03-31

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Astellas Pharma Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2023-02-24

Filing timeline

Last 20 of 256 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-03-04 RESOLUTIONS Resolution
Date Type Category Description
2026-10-14 AA accounts Accounts with accounts type full
2026-06-20 AP01 officers Appoint person director company with name date PDF
2026-06-19 TM01 officers Termination director company with name termination date PDF
2026-02-10 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-02-10 ANNOTATION
2026-02-10 RP01AP01 officers Replacement filing of director appointment with name PDF
2025-10-09 AA accounts Accounts with accounts type full
2025-06-29 TM02 officers Termination secretary company with name termination date PDF
2025-05-27 AP01 officers Appoint person director company with name date PDF
2025-04-03 TM01 officers Termination director company with name termination date PDF
2025-03-04 SH19 capital Capital statement capital company with date currency figure
2025-03-04 SH20 capital Legacy
2025-03-04 CAP-SS insolvency Legacy
2025-03-04 RESOLUTIONS resolution Resolution
2025-01-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-12-16 AA accounts Accounts with accounts type full
2024-01-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-03 AA accounts Accounts with accounts type full
2023-09-08 AP01 officers Appoint person director company with name date PDF
2023-09-04 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
7

last 12 months

Capital events
2

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page